๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetic-pharmacodynamic modeling in drug development: Application to the investigational opioid trefentanil

โœ Scribed by Lemmens, Harry J M; Dyck, John B; Shafer, Steven L; Stanski, Donald R

Book ID
109845341
Publisher
Nature Publishing Group
Year
1994
Tongue
English
Weight
811 KB
Volume
56
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetic-pharmacodynamic modellin
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of drugs โ€“ method development and application to magnesium in sheep
โœ Richard N Upton; Guy L Ludbrook ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› BioMed Central ๐ŸŒ English โš– 737 KB

## Background There have been few reports of pharmacokinetic models that have been linked to models of the cardiovascular system. Such models could predict the cardiovascular effects of a drug under a variety of circumstances. Limiting factors may be the lack of a suitably simple cardiovascular mod

Application of pharmacokineticโ€“pharmacod
Application of pharmacokineticโ€“pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice
โœ Evelyn D. Lobo; David M. Soda; Joseph P. Balthasar ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 263 KB

We have shown that intravenous (i.v.) administration of anti-methotrexate (MTX) antibodies (AMAb) reduces the systemic exposure of intraperitoneal (i.p.) MTX therapy, and we have proposed that AMAb effects on MTX systemic exposure would allow a reduction in MTX-induced systemic toxicity (i.e., produ